Literature DB >> 34459886

Novel actors on the stage of cardiac dysfunction induced by anti-PD1 oncological treatments.

Gilda Varricchi1,2,3,4, Maria Rosaria Galdiero1,2,3,4, Carlo G Tocchetti1,2,3,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34459886     DOI： 10.1093/eurheartj/ehab584

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

Review 1.  Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.

Authors:  Remo Poto; Teresa Troiani; Gjada Criscuolo; Giancarlo Marone; Fortunato Ciardiello; Carlo Gabriele Tocchetti; Gilda Varricchi
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

2.  PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction.

Authors:  Lars Michel; Sebastian Korste; Armin Spomer; Ulrike Barbara Hendgen-Cotta; Tienush Rassaf; Matthias Totzeck
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

Review 3.  Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors.

Authors:  Omoruyi Credit Irabor; Nicolas Nelson; Yash Shah; Muneeb Khan Niazi; Spencer Poiset; Eugene Storozynsky; Dinender K Singla; Douglas Craig Hooper; Bo Lu
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.